Exploration of synthetic lethal interactions as cancer drug targets

Author： Kuiken Hendrik J   Beijersbergen Roderick L  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.6, Iss.11, 2010-11, pp. : 1789-1802

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transcription Factors as Drug Targets in Cancer

By Hurst H.C.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 1857-1863

Elsevier

Access to resources Recommend Favorite

Ubiquitin-specific proteases as cancer drug targets

By Sippl Wolfgang   Collura Vincent   Colland Fréédééric  

Future Oncology, Vol. 7, Iss. 5, 2011-05 ,pp. : 619-632

Future Medicine

Access to resources Recommend Favorite

Macromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 10, 2016-08 ,pp. : 1288-1300

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics in Cancer Treatment: Clinical Implications of Interindividual Variability and Drug Interactions

By Boven E.  

American Journal of Cancer, Vol. 1, Iss. 1, 2002-01 ,pp. : 33-53

Adis International

Access to resources Recommend Favorite

Protein-protein interactions among signaling pathways may become new therapeutic targets in liver cancer (Review)

By Zhang Xiao   Wang Yulan   Wang Jiayi   Sun Fenyong  

Oncology Reports, Vol. 35, Iss. 2, 2016-02 ,pp. : 625-638

Spandidos Publications

Access to resources Recommend Favorite